Diacomit (stiripentol), known to help control seizures in people with Dravet syndrome, also may aid those with other childhood…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
The frequency of seizures decreased substantially for most children with medication-resistant epileptic disorders such as Dravet syndrome at a…
Epidiolex (cannabidiol) reduces the frequency of seizures for most people with Dravet syndrome and also leads to gains…
Treatment with STK-001 led to a marked reduction in seizure frequency, and aided cognition and behavior, among children and adolescents…
A novel gene therapy developed by a team of scientists was able to reduce seizures, improve cognitive scores, and extend…
Researchers have created a new rat model of Dravet syndrome that captures early features of the disease that may…
June is Dravet Syndrome Awareness Month, and the community is coming together to share stories, build support, and increase…
Most caregivers of people with Dravet syndrome report poor sleep quality, according to a study in Germany. Reduced sleep…
Long-term treatment with soticlestat was found to reduce seizure frequency by more than 50% in most Dravet syndrome…
The Dravet Syndrome Foundation (DSF) is funding a collaborative research project to provide a framework for artificial intelligence (AI)-based…